Cargando…

Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?

Detalles Bibliográficos
Autores principales:	Nobile, B., Durand, M., Courtet, P., Van de Perre, P., Nagot, N., Molès, J.P., Olié, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381925/ https://www.ncbi.nlm.nih.gov/pubmed/32773341 http://dx.doi.org/10.1016/j.schres.2020.07.015

Ejemplares similares

Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection
por: Nobile, B., et al.
Publicado: (2020)

The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection
por: Nobile, B., et al.
Publicado: (2021)

Chlorpromazine-induced lenticular opacity
por: Srinivasan, Kavitha, et al.
Publicado: (2020)

Could the SARS-CoV-2 infection be acquired from Smartphones?
por: Law, Siukan, et al.
Publicado: (2020)

Could the SARS-CoV-2 Infection be Acquired via the Eye?
por: Law, Siukan, et al.
Publicado: (2021)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Could SARS-CoV-2 herald a surge of multiple sclerosis?
por: Shalaby, Nevin Mohieldin, et al.
Publicado: (2021)

Current perspectives on chlorpromazine equivalents: Comparing apples and oranges!
por: Danivas, Vijay, et al.
Publicado: (2013)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
por: Prokopez, Cintia R., et al.
Publicado: (2021)

Chlorpromazine-induced Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome
por: Gowda, Shayanth Manche, et al.
Publicado: (2020)

Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave
por: Atripaldi, Luigi, et al.
Publicado: (2021)

Living with COVID-19: could SARS-CoV-2 infection present a ping-pong effect?
por: LAGHI, ALESSANDRO, et al.
Publicado: (2021)

Could anti-ACE2 antibodies alter the results of SARS-CoV-2 Ab neutralization assays?
por: Tobes, Raquel, et al.
Publicado: (2022)

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
por: Plaze, Marion, et al.
Publicado: (2021)

Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
por: Muric, Nemanja N., et al.
Publicado: (2020)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

Could the stethoscope be a SARS-CoV-2 vector?
por: Baeza-Trinidad, Ramón, et al.
Publicado: (2022)

Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?
por: Ni, Xiaotian, et al.
Publicado: (2020)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Excretion of SARS-CoV-2 in human breast milk
por: Costa, S., et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1
por: Lee, Wen-Ying, et al.
Publicado: (2015)

How Does COVID-19 Affect the Neurobiology of Suicide?
por: Conejero, I., et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors
por: Strumila, Robertas, et al.
Publicado: (2021)

Questions concerning the proximal origin of SARS‐CoV‐2
por: Seyran, Murat, et al.
Publicado: (2020)

Serological testing for SARS-CoV-2: Advancements and future challenges
por: Alexopoulos, Harry, et al.
Publicado: (2023)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

High Level of HBV DNA Virus in the Breast Milk Seems not to Contraindicate Breastfeeding
por: Montoya-Ferrer, A, et al.
Publicado: (2015)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Guillain-Barré syndrome associated with SARS-CoV-2 infection()
por: Velayos Galán, A., et al.
Publicado: (2020)

Novel transportation capsule technology could reduce the exposure risk to SARS-CoV-2 infection among healthcare workers: A feasibility study
por: Almuabbadi, Basel, et al.
Publicado: (2020)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_285ts5s0aj8u6ko6bfk7e3p1el